Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-β in patients undergoing coronary artery bypass grafting

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 4, 1997, Pages 763-768

  Sablotzki, Armin ^a   Welters, Ingeborg ^a   Lehmann, Norbert ^a   Menges, Thilo ^a   Görlach, Gerold ^a   Dehne, Marius ^a   Hempelmann, Gunter ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cardiopulmonary bypass; Immunosuppression; Interleukin 10; Transforming growth factor

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; HUMAN; IMMUNITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY DISEASE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030972343     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(97)01154-8     Document Type: Article

References (28)

1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9.
2. Kirklin JK, Westaby S, Blacksone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
3. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 (IL-10) in RA. J Exp Med 1994;179:1517-22.
4. Moore KW, O'Garra A, deWaal Malefyt R, Vieira P, Mosmann TR. Interleukin 10. Annu Rev Immunol 1993;11:165-90.
5. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
6. Hempel L, Korholz D, Bonig H. Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand J Immunol 1995;41:462-6.
7. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
8. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-82.
9. Cohen SBA, Katsikis PD, Feldmann M, Londei M. IL-10 enhances expression of the IL-2 receptor α chain on T cells. Immunology 1994;83:329-32.
10. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol 1990;6:597-641.
11. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-β. Immunol Today 1989;10:258-61.
12. Lefer AM, Tsao P, Aoki N, Palladino MA. Mediation of cardioprotection by transforming growth factor-β. Science 1990;249:61-4.
13. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992;53:833-8.
14. Haeffner-Cavaillon N, Rousselier J-M, Ponzio O. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989;98:1100-6.
15. Kalfin RE, Engelmann RM, Rousou A. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 1993;88:401-6.
16. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normo-thermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:636-41.
17. Chu S-H, Hu R-H, Lee Y-C, Chen K-T. Changes in white blood cells, immunosuppressive acidic protein and interleukin-2 receptor after open heart surgery. Thorac Cardiovasc Surg 1995;43:94-8.
18. Wan S, DeSmet JM, Antoine M, Goldman M, Vincent JL, LeClerc J. Steroid administration in heart and heart-lung transplantation: is the timing adequate? Ann Thorac Surg 1996;61:674-8.
19. Charo IF, Yuen C, Perez HD, Goldstein IM. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells. J Immunol 1986;136:3412-9.
20. Hack CE, De Groot ER, Felt-Bersma RJF. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10.
21. Nijsten NWN, De Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA. Serum levels of interleukin-6 and acute phase responses. Lancet 1987;2:921.
22. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-16.
23. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL. Detection of interleukin-10 in patients with septic shock. Intensive Care Med 1994;20(Suppl 1):9 (Abstr).
24. Boldt J, Heesen M, Müller M, Linke C, Hempelmann G. Interleukin-10 plasma levels in the critically ill. Clin Int Care 1995;6:153-8.
25. Chernoff AE, Granowitz EV, Shapiro L. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immun responses. J Immunol 1995;154:5492-9.
26. Yamamoto H, Hirayama M, Genyea C, Kaplan J. TGF-β mediates natural suppressor activity of IL-2-activated lymphocytes. J Immunol 1994;152:3842-7.
27. Schmitt E, Hoehn P, Huels C. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994;24:793-8.
28. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Transplantation 1995;59:565-72.